"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
Descriptor ID |
D008175
|
MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 6 | 7 | 13 |
1995 | 11 | 5 | 16 |
1996 | 10 | 4 | 14 |
1997 | 9 | 0 | 9 |
1998 | 13 | 1 | 14 |
1999 | 8 | 4 | 12 |
2000 | 12 | 2 | 14 |
2001 | 12 | 5 | 17 |
2002 | 21 | 9 | 30 |
2003 | 32 | 13 | 45 |
2004 | 30 | 6 | 36 |
2005 | 35 | 11 | 46 |
2006 | 31 | 12 | 43 |
2007 | 41 | 8 | 49 |
2008 | 43 | 9 | 52 |
2009 | 36 | 4 | 40 |
2010 | 45 | 4 | 49 |
2011 | 54 | 11 | 65 |
2012 | 51 | 4 | 55 |
2013 | 59 | 5 | 64 |
2014 | 51 | 6 | 57 |
2015 | 73 | 9 | 82 |
2016 | 70 | 11 | 81 |
2017 | 65 | 3 | 68 |
2018 | 74 | 6 | 80 |
2019 | 76 | 7 | 83 |
2020 | 73 | 6 | 79 |
2021 | 85 | 3 | 88 |
2022 | 64 | 0 | 64 |
2023 | 62 | 0 | 62 |
2024 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. J Med Econ. 2024 Jan-Dec; 27(1):292-303.
-
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden. Clin Cancer Res. 2024 02 16; 30(4):824-835.
-
ACR Lung-RADS v2022: Assessment Categories and Management Recommendations. Chest. 2024 Mar; 165(3):738-753.
-
Transfer Learning for Mortality Prediction in Non-Small Cell Lung Cancer with Low-Resolution Histopathology Slide Snapshots. Stud Health Technol Inform. 2024 Jan 25; 310:735-739.
-
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients. Eur J Cancer. 2024 Mar; 199:113530.
-
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy. J Exp Clin Cancer Res. 2024 Jan 02; 43(1):6.
-
"Tool-in-lesion" Accuracy of Galaxy System-A Robotic Electromagnetic Navigation BroncHoscopy With Integrated Tool-in-lesion-Tomosynthesis Technology: The MATCH Study. J Bronchology Interv Pulmonol. 2024 Jan 01; 31(1):23-29.
-
Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT). Lung Cancer. 2024 Jan; 187:107441.
-
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature. Histopathology. 2024 Feb; 84(3):492-506.
-
Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy? J Clin Oncol. 2024 Mar 01; 42(7):858-859.